Omidria Approval History
- FDA approved: Yes (First approved May 30th, 2014)
- Brand name: Omidria
- Generic name: ketorolac and phenylephrine
- Dosage form: Injection
- Company: Omeros Corporation
- Treatment for: Intraocular Lens Replacement Procedures
Omidria (ketorolac and phenylephrine) is an anti-inflammatory and mydriatic combination added to irrigation solution during cataract surgery and intraocular lens replacement procedures.
Development History and FDA Approval Process for Omidria
|Dec 12, 2017||Omeros Corporation Announces FDA Approval of Omidria for Use in Pediatric Patients|
|Jun 2, 2014||FDA Approves Omidria for Use in Cataract and Other Intraocular Lens Replacement Procedures|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.